With much interest we read, the article by Dobbs and Schopflocher. 1 The development of a tool to identify cognitively impaired unsafe aging drivers is a laudable goal, and we applaud their effort. But to our knowledge, no one, including Dobbs and Schopflocher, has yet managed to achieve this goal. We see no compelling evidence in their article to suggest that the Screen for the Identification of Cognitively Impaired Medically At-Risk Drivers, A Modification of the DemTect (SIMARD-MD) is markedly superior to other tools that are already used by physicians and occupational therapists (eg, Trail-Making test, Mini-Mental State Examination (MMSE), Clinical Dementia Rating scale, Clock-Drawing test). What we do see, however, are unfair comparisons of their dual cut-point system to single cutpoint system for other tools. In the 2-pronged analysis reported below, we have attempted to level the playing field when comparing the SIMARD-MD to other tools.
Journal of Primary Care & Community Health 2 (2) context (the purpose of dual cut-points being to prevent mislabeling truly safe drivers as "unsafe" and truly unsafe drivers as "safe"). For the first pair of cut-points, our FP and FN percentages were 7% and 11%, respectively. The corresponding values for Dobbs and Schopflocher were 8% and 8% for Table 3A , and 6% and 11% for Table 3B . In our data, 53% of tests were indeterminate, versus 49% and 50% for Tables 3A and 3B. The predictive values of positive and negative tests (ie, PV+ and PV-) were 83% and 77% for our data, as compared with 86% and 84% (Table 3A) or 80% and 87% (Table 3B ). For the second pair of cut-points, our FP and FN percentages were 1% and 0%, respectively. PV+ was 100% (19/19), and PV-was 0% (0/1). The percentage of indeterminate tests increased from 53% to 86%. Presumably, the same increase in indeterminate cases would occur if dual cut-points that controlled the FP and FN percentages at more appropriate values were applied to the SIMARD-MD.
Our second approach to leveling the playing field was to use the limited data provided by Dobbs and Schopflocher to construct a receiver operating characteristic (ROC) curve for their tool. We added results from one of our previous studies. In that study, we used several approaches to demonstrate that statistically significant associations (such as the regression models presented by Dobbs and Schopflocher; R 2 = 0.22 and 0.27) are no guarantee of predictive value. 2 While our study was not meant to identify the best tool to screen drivers, the data can nonetheless be used to put into perspective the findings of Dobbs and Schopflocher. In Figure 1 , we present the ROC curves for the combination of the MMSE and Trails A, and for the SIMARD-MD. As can be deduced from the figure, there is considerable uncertainty regardless of the approach. The area under the curve was 0.75 for the SIMARD-MD (95% CI = 0.69, 0.81; SE = 0.31) and 0.72 for the MMSE/Trails A combination (95% CI = 0.64, 0.80; SE = 0.41) (we actually obtained better predictive value with a computer-based test but we only present the MMSE and Trails A results because of their administration similarities with the SIMARD-MD.). Admittedly, there are limitations that must be considered. First, our data came from a different study with participants who may not be representative of the population of interest and an on-road evaluation unique to our setting. Second, the area under the curve (AUC) for SIMARD-MD may be somewhat underestimated. (Their article provides only enough information to generate four X-Y pairs to plot on the ROC. If we had access to all possible X-Y pairs, the curve would probably be a bit more convex, and the AUC a bit higher.) Nevertheless, this figure allows the comparison of the SIMARD-MD to other approaches on a more equal footing than we see in the Dobbs and Schopflocher article, and the AUC values for all of the tools are too low for use in the manner suggested.
A final issue worth discussing is the sample used. Dobbs and Schopflocher pointed out that the screening should be administered if there were "red flags that driving competence might be impaired." 1(p125) Hence, it seems very appropriate to use consecutive referrals for a driving assessment as they did, because these are the individuals for whom there is uncertainty about driving ability. However, the addition of healthy controls appears misguided. There was likely little uncertainty about driving fitness in these individuals. Because they were healthy and self-selected, most of these individuals would probably have been predicted to pass. It would be surprising if people at risk of losing their licenses would have volunteered, and indeed only 5 healthy controls failed the on-road evaluation. We would have more confidence in the properties of the tool if the analyses were restricted to a sample representative of the population for which it is intended in clinical practice.
We conclude that as presented, the tool does not have "a high degree of accuracy." 1(p119) When cut-points are chosen to maintain the FP and FN percentages at more appropriate levels, the percentage of cases falling in the gray area and requiring a driving assessment would be unacceptably high. Given the stress and costs associated with such assessments, sending at least 50% of those screened (and possibly in excess of 80%) for driving assessments imposes a considerable and unfair burden on aging drivers. Furthermore, when the SIMARD-MD is compared to other existing tools on a more level playing field, there is no compelling evidence for its superiority. In short, we are still not there yet. 
